A Study to Evaluate the Effectiveness and Safety of Infliximab in Chinese Patients With Active Ulcerative Colitis

This study is currently recruiting participants.

Verified May 2013 by Xian-Janssen Pharmaceutical Ltd.

Study NCT01551290 Information provided by Xian-Janssen Pharmaceutical Ltd.

First Received on March 7, 2012. Last Updated on May 30, 2013 History of Changes

Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:

Conditions listed in this trial

Ulcerative Colitis

Additional conditions recognized in this trial

Colitis
Colitis, Ulcerative
Ulcer

More general conditions related to this trial

Interventions listed in this trial

Infliximab
Placebo

More general drug interventions related to this trial

Sponsors listed in this trial